← Back to Search

Virtual Reality for Hospice Care

N/A

Recruiting

Led By Joshua K Pope

Research Sponsored by Prisma Health-Upstate

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Cognitively intact (has sufficient judgment, planning, organization, and self-control)

Be older than 18 years old

Must not have

Have a condition that interferes with VR usage, including but not limited to seizures, facial injury precluding safe placement of headset

Patients with visual and hearing impairment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is looking at how virtual reality and other outdoor experiences can help patients and their caregivers during end-of-life transitions. The researchers want to find strategies to support patients and caregivers during this difficult time.

Who is the study for?

This trial is for hospice patients experiencing end-of-life transitions and their caregivers. It aims to help with anxiety, pain, and psychological distress using a non-drug approach.

What is being tested?

The study tests Tandem Virtual Reality experiences that simulate nature settings. Patients and caregivers use VR headsets together to see if it helps ease the emotional challenges of end-of-life care.

What are the potential side effects?

Since this intervention uses virtual reality, side effects may include dizziness, nausea or motion sickness. Emotional responses to VR content can vary widely among individuals.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am mentally sharp and can make decisions for myself.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I don't have any health issues that prevent me from using VR safely.

Select...

I have difficulties with my vision or hearing.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptance of Tandem VR

Fear of Death

Perceived benefits and value of Tandem VR

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Tandem Virtual Reality ExperienceExperimental Treatment1 Intervention

Tandem VR Intervention After the surveys are completed, the researchers will share a personalized library of immersive, nature-based, 360-degree VR experiences for the participant-caregiver dyads to choose from based on their VR Intake Form. Once the dyad has determined their desired Tandem VR experience from the library, the researchers will assist the dyads in donning the VR head mounted display (HMD). The researchers will ensure the safety of both dyads while using the HMDs. The researchers will then initiate the Tandem VR experience. The duration of the Tandem VR experience will be 5-15 minutes.

0 / 3Eligibility criteria met